Article: Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEffect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong
AuthorsHo, PL1
Chow, KH1
Lo, WU1
To, KK1
Cheng, VC1
Issue Date2011
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
CitationInternational Journal Of Antimicrobial Agents, 2011, v. 37 n. 3, p. 270-271 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
ISSN0924-8579
2011 Impact Factor: 4.128
2011 SCImago Journal Rankings: 0.232
DOIhttp://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
ISI Accession Number IDWOS:000287476900016
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorHo, PL
dc.contributor.authorChow, KH
dc.contributor.authorLo, WU
dc.contributor.authorTo, KK
dc.contributor.authorCheng, VC
dc.date.accessioned2011-08-26T14:24:50Z
dc.date.available2011-08-26T14:24:50Z
dc.date.issued2011
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationInternational Journal Of Antimicrobial Agents, 2011, v. 37 n. 3, p. 270-271 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
dc.identifier.citeulike8613766
dc.identifier.doihttp://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
dc.identifier.epage271
dc.identifier.hkuros190826
dc.identifier.hkuros209812
dc.identifier.isiWOS:000287476900016
dc.identifier.issn0924-8579
2011 Impact Factor: 4.128
2011 SCImago Journal Rankings: 0.232
dc.identifier.issue3
dc.identifier.openurl
dc.identifier.pmid21227656
dc.identifier.scopuseid_2-s2.0-79951951930
dc.identifier.spage270
dc.identifier.urihttp://hdl.handle.net/10722/137427
dc.identifier.volume37
dc.languageeng
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
dc.publisher.placeNetherlands
dc.relation.ispartofInternational Journal of Antimicrobial Agents
dc.relation.referencesReferences in Scopus
dc.subject.meshCeftazidime - blood - pharmacology - urine
dc.subject.meshCeftriaxone - blood - pharmacology - urine
dc.subject.meshEscherichia coli - drug effects - enzymology - isolation and purification
dc.subject.meshMicrobial Sensitivity Tests
dc.subject.meshbeta-Lactam Resistance
dc.titleEffect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong
dc.typeArticle
Author Affiliations
  1. The University of Hong Kong